Citation Impact
Citing Papers
Foot Drop Stimulation Versus Ankle Foot Orthosis After Stroke
2013
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
A Novel Anti-CD22 Anthracycline-Based Antibody–Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs
2015
International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: Proposed Diagnostic Criteria for Chronic GVHD (Part I)
2013
Autocrine Nitric Oxide Modulates CD95-induced Apoptosis in γδ T Lymphocytes
1997
Cancer treatment and survivorship statistics, 2022
2022 Standout
Classic and Overlap Chronic Graft-versus-Host Disease (cGVHD) Is Associated with Superior Outcome after Extracorporeal Photopheresis (ECP)
2009
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Calcium signalling: dynamics, homeostasis and remodelling
2003 Standout
Natural products: A continuing source of novel drug leads
2013 Standout
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease
2010
Prevalence of Dry Eye Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
2012
Extracorporeal photochemotherapy may improve outcome in children with acute GVHD
2008
Trial Watch: Monoclonal antibodies in cancer therapy
2012
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
TFOS DEWS II Diagnostic Methodology report
2017 Standout
U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease
2008
Extracorporeal photochemotherapy in graft‐versus‐host disease: a longitudinal study on factors influencing the response and survival in pediatric patients
2010
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
2019 StandoutNobel
Cancer stem cells revisited
2017 Standout
Lysophosphatidic Acid-induced Ca2+ Mobilization Requires Intracellular Sphingosine 1-Phosphate Production
2000
TFOS DEWS II pathophysiology report
2017 Standout
Relapsed childhood acute lymphoblastic leukaemia
2013
Fcγ receptors as regulators of immune responses
2007 Standout
The versatility and universality of calcium signalling
2000 Standout
TFOS DEWS II Epidemiology Report
2017 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Antibody–drug conjugates: targeted drug delivery for cancer
2010
Photopheresis in pediatric graft‐versus‐host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature
2007
Antibody–drug conjugates: current status and future directions
2013
Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: Three case reports and review of literature
2008
Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates
2016
Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD
2011
Extracorporeal photopheresis in acute and chronic graft-versus-host disease
2014
Tumour necrosis factor‐α activates a calcium sensitization pathway in guinea‐pig bronchial smooth muscle
1999
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Extracorporeal Photopheresis in Steroid-Refractory Acute or Chronic Graft-versus-Host Disease: Results of a Systematic Review of Prospective Studies
2014
Role of reactive oxygen species (ROS) in apoptosis induction
2000 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Oral Graft-Versus-Host Disease
2008
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Site-specific chemical protein conjugation using genetically encoded aldehyde tags
2012 StandoutNobel
The management and outcome of chronic graft‐versus‐host disease
2007
Photopheresis: Advances and Use in Systemic Sclerosis
2017
Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD
2011
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
2017
Progressive Improvement in Cutaneous and Extracutaneous Chronic Graft-versus-Host Disease after a 24-Week Course of Extracorporeal Photopheresis—Results of a Crossover Randomized Study
2011
New developments for antibody-drug conjugate-based therapeutic approaches
2016
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Mast cells in the development of adaptive immune responses
2005 Standout
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis
2007
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
IgE, mast cells, basophils, and eosinophils
2010 Standout
Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: A study by the Hellenic association of hematology
2011
How I treat refractory acute GVHD
2007
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Successful use of miniphotopheresis for the treatment of graft‐versus‐host disease
2014
Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation
2018
Molecular cloning and characterization of SCaMPER, a sphingolipid Ca2+ release-mediating protein from endoplasmic reticulum.
1996
Nitric oxide and the immune response
2001 Standout
Four cases of corneal perforation in patients with chronic graft-versus-host disease.
2011
Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis
2014
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease
2008
Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug Conjugates
2011
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Current issues in chronic graft-versus-host disease
2014
Cancer treatment and survivorship statistics, 2019
2019 Standout
Ca2+Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase
2003 Standout
Oxime Ligation on the Surface of Mesoporous Silica Nanoparticles
2015 StandoutNobel
Design of Coltuximab Ravtansine, a CD19-Targeting Antibody–Drug Conjugate (ADC) for the Treatment of B-Cell Malignancies: Structure–Activity Relationships and Preclinical Evaluation
2015
Linkers Having a Crucial Role in Antibody–Drug Conjugates
2016
Extracorporeal Photopheresis for Steroid Resistant Graft Versus Host Disease in Pediatric Patients
2007
Hematological Problems in Pediatric Intensive Care
2013 Standout
THE HIGH-AFFINITY Ig E RECEPTOR (FcεRI): From Physiology to Pathology
1999
PK Assays for Antibody–Drug Conjugates: Case Study with Ado-Trastuzumab Emtansine
2013
The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society
2017
Works of Stella Kim being referenced
Sphingolipid-gated Ca2+ Release from Intracellular Stores of Endothelial Cells Is Mediated by a Novel Ca2+-permeable Channel
1995
The Effect of an Ankle‐Foot Orthosis on Temporal Spatial Parameters and Asymmetry of Gait in Hemiparetic Patients
2009
A Phase 1 Study of Denintuzumab Mafodotin (SGN-CD19A) in Adults with Relapsed or Refractory B-Lineage Acute Leukemia (B-ALL) and Highly Aggressive Lymphoma
2015
Interim Analysis of a Phase 1 Study of the Antibody-Drug Conjugate SGN-CD19A in Relapsed or Refractory B-Lineage Non-Hodgkin Lymphoma
2014
Interim Analysis of a Phase 1 Study of the Antibody-Drug Conjugate SGN-CD19A in Relapsed or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma
2014
Phase I Multi-Dose Escalation Study of the Anti-CD19 Maytansinoid Immunoconjugate SAR3419 Administered by Intravenous (IV) Infusion Every 3 Weeks to Patients with Relapsed/ Refractory B-Cell Non-Hodgkin's Lymphoma (NHL).
2009
Phase I Multidose-Escalation Study of the Anti-CD19 Maytansinoid Immunoconjugate SAR3419 Administered by Intravenous Infusion Every 3 Weeks to Patients With Relapsed/Refractory B-Cell Lymphoma
2012
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD
2005
A Phase 1 Study of Denintuzumab Mafodotin (SGN-CD19A) in Relapsed/Refactory B-Lineage Non-Hodgkin Lymphoma
2015